Ruth Ben Yakar
Board of Directors
Cellect Biosciences
Israel
Biography
Dr. Ben Yakar Has Over 22 Years Of Experience In The Biomedical Field, Including 15 Years Of Management And Leading Diverse Activities. Dr. Ben Yakar Is The CEO Of BioSight, A Clinical-Phase Biotech Company And A Business Consultant To Biomed Companies. She Formerly Served As CEO Of Biotech Companies Procognia And Thrombotech, As The Chief Business Officer Of YEDA, The Technology Transfer Company Of The Weizmann Institute Of Science, And As VP In Several Biotech Companies.
Research Interest
Biomedical
